Neurons undergo apoptosis in animal and cell culture models of diabetes

Neurobiology of Disease

Volumn 6, Issue 5, 1999, Pages 347-363

  Russell, James W ^a,b   Sullivan, Kelli A ^a   Windebank, Anthony J ^c   Herrmann, David N ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; GLUCOSE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CYTOPLASM; DIABETIC NEUROPATHY; DISEASE SEVERITY; ENZYME ACTIVATION; HYPERGLYCEMIA; MALE; MITOCHONDRION; NERVE CELL; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SCHWANN CELL; SPINAL GANGLION; STREPTOZOCIN DIABETES;

EID: 0032702965     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0254     Document Type: Article

References (71)

1. Anderton B. H. Alzheimer's disease: Clues from flies and worms. Curr. Biol. 9:1999;106-109.
2. Apfel S. C., Arezzo J. C., Brownlee M., Federoff H., Kessler J. A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634:1994;7-12.
3. Baumgartner-Parzer S. M., Wagner L., Pettermann M., Grillari J., Gessl A., Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes. 44:1995;1323-1327.
4. Bottenstein J. E. Serum-free culture of dissociated chick embryo sensory neurons. Shahar A., de Vellis J., Vernadakis A., Haber B. A Dissection and Tissue Culture Manual of the Nervous System. 1989;227-229 A. R. Liss, New York.
5. Cameron N. E., Cotter M. A., Archibald V., Dines K. C., Maxfield E. K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 37:1994;449-459.
6. Cheng H.-L., Feldman E. L. Bi-directional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J. Biol. Chem. 273:1998;14560-14565.
7. Coggeshall R. E. Verification of the method of determining neural numbers. J. Neurosci. Methods. 40:1991;87-90.
8. Coggeshall R. E., Chung K. The determination of an empirical correction factor to deal with the problem of nucleolar splitting in neuronal counts. J. Neurosci. Methods. 10:1984;149-155.
9. N. Engl. J. Med. 329:1993;977-986.
10. Deckwerth T. L., Johnson E. M. Jr. Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 165:1994;63-72.
11. Ann. Intern. Med. 122:1995;561-568.
12. Dyck P. J., Giannini C. Pathologic alterations in the diabetic neuropathies of humans: A review. J. Neuropathol. Exp. Neurol. 55:1996;1181-1193.
13. Dyck P. J., Karnes J., O'Brien P. C. Diabetic Neuropathy. 1987;Saunders, Philadelphia.
14. Dyck P. J., Kratz K. M., Lehman K. A. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology. 41:1991;799-807.
15. Dyck P. J., Lambert E. H., Windebank A. J., Lais A. A., Sparks M. F., Karnes J., Sherman W. R., Hallcher L. M., Low P. A., Service F. J. Acute hyperosmolar hyperglycemia causes axonal shrinkage and reduced nerve conduction velocity. Exp. Neurol. 71:1981;507-514.
16. Erdem S., Mendell J. R., Sahenk Z. Fate of Schwann cells in CMT1A and HNPP: Evidence for apoptosis. J. Neuropathol. Exp. Neurol. 57:1998;635-642.
17. Feldman E. L., Stevens M. J., Greene D. A. Pathogenesis of diabetic neuropathy. Clin. Neurosci. 4:1997a;365-370.
18. Feldman E. L., Sullivan K. A., Kim B., Russell J. W. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol. Dis. 4:1997b;201-214.
19. Frisch S. M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:1994;619-625.
20. Frisch S. M., Ruoslahti E. Integrins and anoikis. Curr. Opin. Cell Biol. 9:1997;701-706.
21. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1993;493-501.
22. Giordano C., Stassi G., Todaro M., De Maria R., Richiusa P., Scorsone A., Giordano M., Galluzzo A. Low bcl-2 expression and increased spontaneous apoptosis in T-lymphocytes from newly-diagnosed IDDM patients. Diabetologia. 38:1995;953-958.
23. Gray F., Chretien F., Adie-Biassette H., Dorandeu A., Ereau T., Delisle M. B., Kopp N., Ironside J. W., Vital C. Neuronal apoptosis in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 58:1999;321-328.
24. Green D. R., Reed J. C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
25. Greenbaum D., Richardson P. C., Salmon M. V., Urich H. Pathological observations on six cases of diabetic neuropathy. Brain. 87:1964;201-214.
26. Greene D. A., Feldman E. L., Stevens M. J., Sima A. A. F., Albers J. W., Pfeifer M. A. Diabetic neuropathy. Porte D. Jr., Sherwin R. Diabetes Mellitus. 1997;1009-1076 Appleton & Lange, East Norwalk.
27. Hellweg R., Hartung H.-D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res. 26:1990;258-267.
28. Hounsom L., Tomlinson D. R. Does diabetic neuropathy develop in animal models. Clin. Neurosci. 4:1997;380-389.
29. Kerezoudi E., King R. H., Muddle J. R., O'Neill J. A., Thomas P. K. Influence of age on the late retrograde effects of sciatic nerve section in the rat. J. Anat. 187:1995;27-35.
30. Kerr J. F. R., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-257.
31. Kitamura Y., Taniguchi T., Shimohama S. Apoptotic cell death in neurons and glial cells: Implications for Alzheimer's disease. Jpn. J. Pharmacol. 79:1999;1-5.
32. Kluck R. M., Bossy-Wetzel E., Green D. R., Newmeyer D. D. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science. 275:1997;1132-1136.
33. Korinkova P., Lodin Z. The metabolism of glucose of nerve cells cultivated under different conditions. Acta Histochem. 56:1976;47-65.
34. Labat-Moleur F., Guillermet C., Lorimier P., Robert C., Lantuejoul S., Brambilla E., Negoescu A. TUNEL apoptotic cell detection in tissue sections: Critical evaluation and improvement. J. Histochem. Cytochem. 46:1998;327-334.
35. Louagie H., Cornelissen M., Philippe J., Vral A., Thierens H., De Ridder L. Flow cytometric scoring of apoptosis compared to electron microscopy in gamma irradiated lymphocytes. Cell Biol. Int. 22:1999;277-283.
36. Matthews C. C., Dieckmann C., Feldman E. L. IGF-I rescues neurons from hyperosmotic-induced programmed cell death. Endocr. Soc. Abstr. 82:1995;OR28-3.
37. Matthews C. C., Feldman E. L. Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic induced programmed cell death. J. Cell. Physiol. 166:1996;323-331.
38. Matthews C. C., Odeh H., Feldman E. L. Insulin-like growth factor-I is an osmoprotectant in human neuroblastoma cells. Neuroscience. 79:1997;525-534.
39. Mignotte B., Vayssiere J.-L. Mitochondria and apoptosis. Eur. J. Biochem. 252:1998;1-15.
40. O'Brien B. A., Harmon B. V., Cameron D. P., Allan D. J. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J. Pathol. 178:1996;176-181.
41. O'Brien B. A., Harmon B. V., Cameron D. P., Allan D. J. Apoptosis is the mode of B-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes. 46:1997;750-757.
42. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1:1978;168-188.
43. Powell H., Knox D., Lee S., Charters A. C., Orloff M., Garrett R., Lampert P. Alloxan diabetic neuropathy: Electron microscopic studies. Neurology. 27:1977;60-66.
44. Rauvala H., Pihlaskari R., Laitinen J., Merenmies J. Extracellular adhesive molecules in neurite growth. Biosci. Rep. 9:1989;1-12.
45. Russell J., Karnes J., Dyck P. Sural nerve myelinated fiber density differences associated with meaningful changes in clinical and electrophysiological measurements. J. Neurol. Sci. 135:1996;114-117.
46. Russell J. W., Feldman E. L. Insulin-like growth factor-I (IGF-I) protects sensory neurons from glucotoxicity. Ann. Neurol. 40:1996.
47. Russell J. W., Feldman E. L. Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose. Horm. Metab. Res. 31:1999;90-96.
48. Russell J. W., Herrmann D. N., Sullivan K. A., Feldman E. L. Hyperglycemia induces programmed cell death in sensory neurons in vivo and in vitro. Endocr. Soc. Abstr. 218:1998a;P1-475.
49. Russell J. W., van Golen C., Feldman E. L. IGF-I prevents glucose mediated loss of mitochondrial membrane integrity and programmed cell death in models of diabetic neuropathy. Ann. Neurol. 44:1998b;439.
50. Russell J. W., Windebank A. J. Electrophysiological and pathological characteristics of suramin induced neuropathy. Neurology. 43:1993;A174.
51. Russell J. W., Windebank A. J., McNiven M. A., Brat D. J., Brimijoin W. S. Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity. Brain Res. 676:1995;258-267.
52. Russell J. W., Windebank A. J., Podratz J. L. Role of nerve growth factor in suramin neurotoxicity studied in vitro. Ann. Neurol. 36:1994;221-228.
53. Russell J. W., Windebank A. J., Schenone A., Feldman E. L. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal. J. Neurobiol. 36:1998;455-467.
54. Sano T., Umeda F., Hashimoto T., Nawata H., Utsumi H. Oxidative stress measurement in vivo electron spin resonance spectroscopy in rats with streptozotocin-induced diabetes. Diabetologia. 41:1998;1355-1360.
55. Sasaki H., Schmelzer J. D., Zollman P. J., Low P. A. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats. Acta Neuropathol. 93:1997;118-128.
56. Schmitz G., Walter T., Seibl R., Kessler C. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal. Biochem. 192:1991;222-231.
57. Sharma A. K., Duguid I. G. M., Blanchard D. S., Thomas P. K. The effect of insulin treatment on myelinated nerve fiber maturation and integrity and on body growth in streptozocin-diabetic rats. J. Neurol. Sci. 67:1985;285-297.
58. Sharma A. K., Thomas P. K. Animal models: Pathology and pathophysiology. Dyck P. J., Thomas P. K., Asbury A. K., Winegrad A. I., Porte D. Jr. Diabetic Neuropathy. 1987;237-252 Saunders, Philadelphia.
59. Shigenaga M. K., Hagen T. M., Ames B. N. Oxidative damage and mitochondrial decay in ageing. Proc. Natl. Acad. Sci. USA. 91:1994;10771-10778.
60. Sidenius P., Jakobsen J. Reduced perikaryal volume of lower motor neurons and primary sensory neurons in early experimental diabetes. Diabetes. 29:1980;182-186.
61. Singleton J. R., Dixit V. M., Feldman E. L. Type I insulin-like growth factor receptor activation regulates apoptotic proteins. J. Biol. Chem. 271:1996a;31791-31794.
62. Singleton J. R., Randolph A. E., Feldman E. L. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis. Cancer Res. 56:1996b;4522-4529.
63. Srinivasan A., Roth K. A., Sayers R. O., Shindler K. S., Wong A. M., Fritz L. C., Tomaselli K. J. In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system. Cell Death Differ. 5:1998;1004-1016.
64. Sullivan K. A., Kim B., Russell J. W., Feldman E. L. IGF-I in neuronal differentiation and neuroprotection. Muller E. IGFs in the Nervous System. 1998;28-46 Springer-Verlag, Milan.
65. Susin S. A., Zamzami N., Castedo M., Daugas E., Wang H. G., Geley S., Fassy F., Reed J. C., Kroemer G. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186:1997;25-37.
66. Tamura E., Parry G. J. Severe radicular pathology in rats with longstanding diabetes. J. Neurol. Sci. 127:1994;29-35.
67. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
68. Tomlinson D. R., Fernyhough P., Diemel L. T. Neurotrophins and peripheral neuropathy. Philos. Trans. R. Soc. London B: Biol. Sci. 351:1996;455-462.
69. Tomlinson D. R., Fernyhough P., Diemel L. T. Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors. Diabetes. 46:1997;S43-S49.
70. Windebank A., Smith A., Russell J. The effect of nerve growth factor, ciliary neurotrophic factor, and ACTH analogs on cisplatin neurotoxicity in vitro. Neurology. 44:1994;488-494.
71. Zigler D. Electrophysiological assessment: Relationship to glycaemic control. Hotta N., Greene D. A., Ward J. D., Sima A. A. F., Boulton A. J. M. Diabetic Neuropathy. 1995;59-69 Elsevier, Amsterdam.